Dark Forest Capital Management LP raised its position in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 350.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 52,470 shares of the health services provider's stock after buying an additional 40,829 shares during the period. Dark Forest Capital Management LP's holdings in Select Medical were worth $989,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently modified their holdings of SEM. Smartleaf Asset Management LLC raised its stake in shares of Select Medical by 179.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock valued at $43,000 after buying an additional 1,473 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in shares of Select Medical in the 3rd quarter valued at about $81,000. Covestor Ltd grew its holdings in shares of Select Medical by 33.5% during the fourth quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock worth $93,000 after purchasing an additional 1,244 shares in the last quarter. Cibc World Markets Corp bought a new position in shares of Select Medical in the fourth quarter worth approximately $191,000. Finally, Vista Finance LLC bought a new stake in Select Medical during the fourth quarter worth about $193,000. Hedge funds and other institutional investors own 89.48% of the company's stock.
Select Medical Stock Performance
NYSE:SEM traded up $0.22 on Tuesday, hitting $18.34. The stock had a trading volume of 213,187 shares, compared to its average volume of 826,955. The business's 50-day simple moving average is $17.02 and its two-hundred day simple moving average is $22.12. Select Medical Holdings Co. has a 52-week low of $14.99 and a 52-week high of $40.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a market cap of $2.37 billion, a price-to-earnings ratio of 11.11, a price-to-earnings-growth ratio of 0.64 and a beta of 1.38.
Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.11). The business had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. As a group, research analysts predict that Select Medical Holdings Co. will post 1.17 earnings per share for the current year.
Select Medical Cuts Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, March 13th. Stockholders of record on Monday, March 3rd were issued a $0.0625 dividend. This represents a $0.25 annualized dividend and a dividend yield of 1.36%. The ex-dividend date was Monday, March 3rd. Select Medical's dividend payout ratio (DPR) is presently 15.15%.
Analyst Ratings Changes
SEM has been the topic of a number of recent research reports. Mizuho began coverage on shares of Select Medical in a research report on Wednesday, April 16th. They set an "outperform" rating and a $25.00 price target on the stock. StockNews.com raised Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, February 21st. Royal Bank of Canada reduced their price target on Select Medical from $47.00 to $23.00 and set an "outperform" rating on the stock in a research report on Monday, February 24th. Benchmark upgraded Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price objective for the company in a research report on Monday, February 24th. Finally, UBS Group cut their price target on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a report on Friday, January 3rd. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $26.80.
Get Our Latest Stock Report on Select Medical
Select Medical Company Profile
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Articles

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.